Benchmark Reiterates Speculative Buy Rating for ImmunoPrecise Antibodies (NASDAQ:IPA)
ImmunoPrecise Antibodies (NASDAQ:IPA – Get Free Report)‘s stock had its “speculative buy” rating restated by analysts at Benchmark in a research report issued on Tuesday,Benzinga reports. They presently have a $3.00 price target on the stock. Separately, HC Wainwright dropped their price objective on shares of ImmunoPrecise Antibodies from $7.00 to $5.00 and set a […]
ImmunoPrecise Antibodies (NASDAQ:IPA – Get Free Report)‘s stock had its “speculative buy” rating restated by analysts at Benchmark in a research report issued on Tuesday,Benzinga reports. They presently have a $3.00 price target on the stock. Separately, HC Wainwright dropped their price objective on shares of ImmunoPrecise Antibodies from $7.00 to $5.00 and set a […]
